Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-02-14 10:15 am Purchase | 13G | TRANSPHORM INC TGAN | AMERIPRISE FINANCIAL INC AMP | 4,943,812 7.97% | 1,138,264 (+29.91%) | View |
| 2024-02-13 1:41 pm Purchase | 13G | TRANSPHORM INC TGAN | Yaskawa Electric CORP | 4,420,000 7.05% | 650,000 (+17.24%) | View |
| 2024-02-12 12:05 pm Purchase | 13G | TRANSPHORM INC TGAN | SAS Capital Co. Ltd. | 5,771,500 9.16% | 937,500 (+19.39%) | View |
| 2024-01-25 07:03 am Sale | 13G | TRANSPHORM INC TGAN | HIRSCHMAN ORIN | 1,263,282 2% | -3,831,690 (-75.21%) | View |
| 2024-01-11 4:40 pm Unchanged | 13D | TRANSPHORM INC TGAN | KKR Phorm Investors L.P. | 24,724,468 39.7% | 0 (Unchanged) | View |
| 2023-07-25 4:19 pm Purchase | 13D | TRANSPHORM INC TGAN | KKR Phorm Investors L.P. | 24,724,468 39.8% | 1,735,988 (+7.55%) | View |
| 2023-02-15 06:19 am Sale | 13G | TRANSPHORM INC TGAN | HIRSCHMAN ORIN | 5,094,972 8.8% | -258,108 (-4.82%) | View |
| 2023-02-14 10:20 am Purchase | 13G | TRANSPHORM INC TGAN | AMERIPRISE FINANCIAL INC AMP | 3,805,548 6.72% | 303,926 (+8.68%) | View |
| 2023-02-07 2:14 pm Unchanged | 13G | TRANSPHORM INC TGAN | SAS Capital Co. Ltd. | 4,834,000 8.41% | 0 (Unchanged) | View |
| 2022-06-03 4:30 pm Purchase | 13D | TRANSPHORM INC TGAN | KKR Phorm Investors L.P. | 22,988,480 40.4% | 22,988,480 (New Position) | View |
| 2022-02-14 12:24 pm Purchase | 13G | TRANSPHORM INC TGAN | AMERIPRISE FINANCIAL INC AMP | 3,501,622 6.6% | 361,222 (+11.50%) | View |
| 2022-02-11 3:40 pm Purchase | 13G | TRANSPHORM INC TGAN | HIRSCHMAN ORIN | 5,353,080 9.7% | 42,455 (+0.80%) | View |
| 2021-12-08 4:38 pm Purchase | 13G | TRANSPHORM INC TGAN | SAS Capital Co. Ltd. | 4,834,000 9.08% | 4,834,000 (New Position) | View |
| 2021-11-08 06:15 am Purchase | 13D | TRANSPHORM INC TGAN | KKR Phorm Investors L.P. | 22,988,480 45.8% | 1,812,500 (+8.56%) | View |
| 2021-10-07 1:42 pm Purchase | 13G | TRANSPHORM INC TGAN | Yaskawa Electric CORP | 3,770,000 8.5% | 3,770,000 (New Position) | View |
| 2021-06-30 10:04 am Purchase | 13G | TRANSPHORM INC TGAN | AMERIPRISE FINANCIAL INC AMP | 3,140,400 7.75% | 3,140,400 (New Position) | View |
| 2020-07-21 4:45 pm Unchanged | 13D | TRANSPHORM INC TGAN | KKR Phorm Investors L.P. | 21,175,980 60.3% | 0 (Unchanged) | View |
| 2020-03-13 5:01 pm Purchase | 13D | TRANSPHORM INC TGAN | KKR Phorm Investors L.P. | 21,175,980 60.2% | 21,175,980 (New Position) | View |
| 2020-02-25 5:28 pm Unchanged | 13G | TRANSPHORM INC TGAN | Nexperia B.V. | 4,000,000 11.4% | 0 (Unchanged) | View |
| 2020-02-24 6:27 pm Purchase | 13G | TRANSPHORM INC TGAN | Nexperia B.V. | 4,000,000 11.4% | 4,000,000 (New Position) | View |